Investors have been reading and rereading the contingency plans of agencies like the Department of Health and Human Services.
A short lapse in Congressional funding for the government wouldn’t halt the drug-approval reviews that companies and their investors rely on. But any pause longer than a month or two could hurt.
Medicare and Medicaid will keep processing health-insurance claims, with about half their staff still on the job thanks to the programs’ mandatory funding. More than 81% of the Food and Drug Administration’s 19,250 employees will be retained to review and approve new medical products, oversee factories, and manage product recalls.
But in the event of a lapse in Congressional appropriations, the FDA won’t be collecting new user fees. That raises the question of how long the carry-over user fees will last, wrote Raymond James analyst Chris Meekins in a Tuesday research note.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
| FDA advisers weigh divisive ALS drug todayThere's a heated debate over the investigational treatment called NurOwn.
Read more »
Viatris and Ocuphire Pharma get FDA green light for eye treatmentViatris Inc. and Ocuphire Pharma Inc. said Wednesday that the U.S. Food and Drug Administration has approved Ryzumvi to treat the side effects of...
Read more »
FDA to Review Experimental ALS Treatment This WeekThe Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig's disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease. Those advocates still face one giant hurdle: FDA...
Read more »
Costco Is Recalling Butternut Squash Due to E. Coli Risk, FDA WarnsThe FDA is warning that Costco is recalling butternut squash due to a potential E. coli contamination risk.
Read more »
Withings’ smartest scale just got FDA clearance.The Withings Body Scan Connected Health Station is an extra as hell scale. It’s got a handle for 6-lead EKGs and can purportedly take segmented body fat scans. As in, differentiate how much fat you carry in your arms versus legs, etc. Withings also claims the scale’s EDA sensors can measure your foot sweat to gauge your nerve health. Wild. In any case, Withings first announced this baby nearly two years ago at CES 2022 — and this is a good example of how long FDA clearance can take as this $399.95 scale will be available at the end of September 2023.
Read more »
FDA updates Ozempic label with potential blocked intestines side effect, also reported with Wegovy and MounjaroThe FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
Read more »